Skip to main content
Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.03
-0.47 (-6.27%)
At close: Feb 27, 2026, 4:00 PM EST
6.86
-0.17 (-2.38%)
After-hours: Feb 27, 2026, 7:11 PM EST

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $741.00K in the quarter ending September 30, 2025, a decrease of -41.61%. This brings the company's revenue in the last twelve months to $2.65M, down -55.88% year-over-year. In the year 2024, Aligos Therapeutics had annual revenue of $3.95M, down -74.60%.

Revenue (ttm)
$2.65M
Revenue Growth
-55.88%
P/S Ratio
16.35
Revenue / Employee
$37,800
Employees
70
Market Cap
43.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ALGS News

More News